ReWalk Robotics Correlations
LFWD Stock | 1.62 0.05 3.18% |
The current 90-days correlation between ReWalk Robotics and Genfit is 0.17 (i.e., Average diversification). The correlation of ReWalk Robotics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ReWalk Robotics Correlation With Market
Significant diversification
The correlation between ReWalk Robotics and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ReWalk Robotics and DJI in the same portfolio, assuming nothing else is changed.
ReWalk |
Moving together with ReWalk Stock
0.66 | EVH | Evolent Health | PairCorr |
0.67 | TFX | Teleflex Incorporated | PairCorr |
0.68 | GCTK | GlucoTrack | PairCorr |
0.76 | ACET | Adicet Bio | PairCorr |
0.66 | VALN | Valneva SE ADR | PairCorr |
Moving against ReWalk Stock
0.56 | LNSR | LENSAR Inc | PairCorr |
0.48 | CAH | Cardinal Health Earnings Call This Week | PairCorr |
0.46 | HQY | HealthEquity | PairCorr |
0.44 | HSTM | HealthStream | PairCorr |
0.41 | HIMS | Hims Hers Health Sell-off Trend | PairCorr |
0.4 | AHG | Akso Health Group | PairCorr |
0.61 | ATEC | Alphatec Holdings Downward Rally | PairCorr |
0.51 | STRM | Streamline Health | PairCorr |
0.48 | PRVA | Privia Health Group | PairCorr |
0.48 | TMCI | Treace Medical Concepts | PairCorr |
0.35 | MMSI | Merit Medical Systems | PairCorr |
0.42 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.35 | GILD | Gilead Sciences | PairCorr |
Related Correlations Analysis
0.58 | 0.0 | -0.51 | 0.0 | 0.0 | -0.24 | MAT | ||
0.58 | 0.0 | -0.53 | 0.0 | 0.0 | -0.12 | GNFT | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | GWIN | ||
-0.51 | -0.53 | 0.0 | 0.0 | 0.0 | 0.43 | CNLFF | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | HYWI | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | OMHE | ||
-0.24 | -0.12 | 0.0 | 0.43 | 0.0 | 0.0 | DOOO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ReWalk Stock performing well and ReWalk Robotics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ReWalk Robotics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MAT | 1.36 | (0.07) | 0.00 | (0.74) | 0.00 | 3.09 | 11.42 | |||
GNFT | 1.95 | (0.75) | 0.00 | (1.62) | 0.00 | 2.96 | 19.03 | |||
GWIN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CNLFF | 0.03 | 0.01 | 0.00 | (0.24) | 0.00 | 0.00 | 1.02 | |||
HYWI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
OMHE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
DOOO | 1.68 | (0.12) | 0.00 | (0.40) | 0.00 | 3.49 | 11.25 |
ReWalk Robotics Corporate Management
Almog Adar | VP Officer | Profile | |
Michael Lawless | Chief Officer | Profile | |
Miri Pariente | Regulatory Operations | Profile | |
Jeannine Lynch | Vice Strategy | Profile | |
Kathleen ODonnell | Vice Development | Profile | |
Charles Remsberg | Chief Officer | Profile |